Asian women are diagnosed more at a premenopausal age, with larger luminal B tumors, with node-positive disease, and have active tumor micro-environments with frequent TP53 mutations vs. Caucasian women warranting aggressive treatment strategies [47–50]. This evidence concerns the gene TP53 and neoplasm.